Rahaman Ademolu Ahmed, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nigeria | 7 | 2023 | 781 | 0.390 |
Why?
|
| RNA, Viral | 3 | 2021 | 2867 | 0.220 |
Why?
|
| Cefotaxime | 1 | 2022 | 36 | 0.210 |
Why?
|
| Immunogenetics | 1 | 2021 | 62 | 0.190 |
Why?
|
| Interinstitutional Relations | 1 | 2021 | 235 | 0.180 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 219 | 0.170 |
Why?
|
| HIV Infections | 2 | 2022 | 17542 | 0.150 |
Why?
|
| South Africa | 1 | 2022 | 1873 | 0.130 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 868 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 1512 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1396 | 0.110 |
Why?
|
| Viral Load | 1 | 2022 | 3385 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 1639 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 2038 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4780 | 0.080 |
Why?
|
| Prevalence | 2 | 2022 | 15851 | 0.080 |
Why?
|
| Genomics | 1 | 2021 | 5924 | 0.060 |
Why?
|
| HIV-1 | 1 | 2020 | 6951 | 0.050 |
Why?
|
| beta-Globins | 1 | 2022 | 111 | 0.050 |
Why?
|
| Africa, Western | 1 | 2021 | 160 | 0.050 |
Why?
|
| Enterococcus | 1 | 2022 | 158 | 0.050 |
Why?
|
| Vaginal Smears | 1 | 2022 | 505 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 546 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2022 | 706 | 0.040 |
Why?
|
| Quality Control | 1 | 2020 | 835 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 644 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1011 | 0.030 |
Why?
|
| Laboratories | 1 | 2020 | 463 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2021 | 673 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 14672 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2022 | 1139 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 1969 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 859 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1758 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4572 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2840 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 767040 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2568 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2022 | 4209 | 0.020 |
Why?
|
| Base Sequence | 1 | 2021 | 12414 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3667 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3236 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4787 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5363 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10254 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26325 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 36485 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 42606 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 223233 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 59548 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 59980 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80771 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 89046 | 0.010 |
Why?
|
| Female | 2 | 2022 | 396660 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81659 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 171319 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 223317 | 0.000 |
Why?
|
| Male | 1 | 2022 | 364203 | 0.000 |
Why?
|